Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METTL3 | Q86U44 | 1/20 | 0.42 |
| ▸ | PDE8B | O95263 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.36 |
| ▸ | F2RL3 | Q96RI0 | 2/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | SUV39H2 | Q9H5I1 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.35 |
| ▸ | FEN1 | P39748 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3251052 | 0.86 | PDE8B (0.38) | PDE8BHCRTR2L3MBTL1LMNA | |
| SCHEMBL7797391 | 0.84 | KDM4E (0.44) | METTL3PDE8BKDM1ACHEK2PRMT5 | |
| SCHEMBL2538398 | 0.83 | PDE8B (0.42) | METTL3PDE8BKDM1ACHEK2PRMT5 | |
| SCHEMBL2121708 | 0.82 | METTL3 (0.54) | METTL3PDE8BKDM1APRMT5HCRTR2 | |
| SCHEMBL2121861 | 0.82 | KDM4E (0.53) | METTL3PDE8BKDM1APRMT5LMNA | |
| SCHEMBL2120295 | 0.81 | TLR9 (0.45) | METTL3PDE8BCHEK2F2RL3L3MBTL1 | |
| SCHEMBL2120937 | 0.80 | METTL3 (0.44) | METTL3PDE8BKDM1ACHEK2PRMT5 | |
| SCHEMBL2512853 | 0.80 | METTL3 (0.45) | METTL3PDE8BKDM1ACHEK2PRMT5 | |
| SCHEMBL86245 | 0.80 | PDE8B (0.42) | METTL3PDE8BKDM1ACHEK2PRMT5 | |
| SCHEMBL12225864 | 0.79 | PDE8B (0.43) | METTL3PDE8BKDM1ACHEK2PRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8093255-B2 | Imidazo[1,2-A]pyrimidines as orexin receptor antagonists | GLAXO GROUP LIMITED (GB) | 2012-01-10 | — | — | US | disclosed |
| US-8093255-B2 | Imidazo[1,2-A]pyrimidines as orexin receptor antagonists | GLAXO GROUP LIMITED (GB) | 2012-01-10 | — | — | US | disclosed |
| US-8093255-B2 | Imidazo[1,2-A]pyrimidines as orexin receptor antagonists | GLAXO GROUP LIMITED (GB) | 2012-01-10 | — | — | US | disclosed |
| EP-2358712-A1 | PIPERIDINE DERIVATIVES USEFUL AS OREXIN RECEPTOR ANTAGONISTS | Glaxo Group Limited (GB) | 2011-08-24 | — | — | EP | disclosed |
| US-20100160344-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2010-06-24 | — | — | US | disclosed |
| US-20100160344-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2010-06-24 | — | — | US | disclosed |
| WO-2010060471-A1 | PIPERIDINE DERIVATIVES USEFUL AS OREXIN RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2010-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160344-A1 | NOVEL COMPOUNDS | BRD4, HDAC6, ENTPD5 | METTL3 3887/4885PDE8B 227/4885KDM1A 3905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.